Home



Search Management Forum or the Web

ALPHABETICAL INDEX OF EVENTS:

ABRIDGED PRODUCT LICENCE APPLICATIONS

ACADEMIC & NON COMMERCIAL TRIALS – IMPLICATIONS OF THE

ADR MONITORING AND PHARMACOVIGILANCE

ASSAYS FOR CHARACTERISING CLINICAL BIOLOGICAL MACROMOLECULES

BASIC COURSE ON PHARMACOVIGILANCE

BIOTECHNOLOGY FOR THE NON-BIOTECHNOLOGIST March
September

BORDERLINES BETWEEN COSMETICS AND DRUGS

BRAILLE FOR PHARMACEUTICAL PACKAGING

CHANGES IN THE NHS

CHEMICAL REFERENCE STANDARDS

CLINICAL TRIALS IN RESPIRATORY MEDICINE

CONTROLLING EXCIPIENTS

CRITICAL SUCCESS FACTORS FOR POM TO P SWITCHING

CTD: CLINICAL OVERVIEW AND CLINICAL SUMMARY

CTD & eCTD GLOBAL QUALITY DOSSIER

DATA PROTECTION ISSUES IN THE PHARMACEUTICAL INDUSTRY

EUROPEAN REGULATORY PROCEDURES AND STANDARDS

EU CHEMISTRY AND PHARMACY REGULATORY PROCEDURES AND REQUIREMENTS FOR MAAs
CORK, IRELAND

BUDAPEST, HUNGARY

BARCELONA, SPAIN

EU CLINICAL TRIAL DIRECTIVE - ONE YEAR ON

FDA APPROVAL PROCESS FOR BIOLOGICAL PRODUCTS

FDA GENERIC DRUG APPROVAL PROCESS

GCP COURSE
FOUNDATION LEVEL

GMP FOR IMPs

HOW TO PREPARE CLINICAL SOPs

IMPURITIES IMPURITIES
IN BARCELONA

INTRODUCTORY OVERVIEW OF THE PHARMACEUTICAL INDUSTRY

MICROBIOLOGY FOR THE NON-MICROBIOLOGIST
In Amsterdam

MONITORING TO GCP & THE EU CLINICAL TRIAL DIRECTIVE

NICE & THE PHARMACEUTICAL INDUSTRY

PARALLEL TRADE

PATENTABILITY PROBLEMS IN MEDICAL TECHNOLOGY

PERIODIC SAFETY UPDATE REPORTS

PHARMACEUTICAL APPLICATIONS IN THE EU

PHARMACEUTICAL REGULATORY AFFAIRS IN LATIN AMERICA AND THE CARIBBEAN

PHARMACEUTICAL REGULATORY AFFAIRS IN THE MIDDLE EAST

PHARMACEUTICAL REGULATORY AFFAIRS IN ASIA

PHARMACOKINETICS/DYNAMICS
ADVANCED COURSE

PHARMACOKINETICS: WORKSHOP FOR BEGINNERS
INTERMEDIATE COURSE

PHARMACOVIGILANCE: Course for Clinical Trials/Studies Personnel

PHARMACOVIGILANCE: COMPLIANCE & QUALITY ASSURANCE

QUALIFIED PERSON
in Pharmacovigilance

QUALITY (CMC) CONSIDERATIONS FOR JAPAN

REGULATORY ASPECTS OF HERBAL MEDICINE

SCIENTIFIC ADVICE

'SMART' PHARMA PROCESSES

STABILITY TESTING
APRIL
OCTOBER

SUCCESSFUL MEDICAL WRITING

SUCCESSFUL PHARMACEUTICAL PROJECT MANAGEMENT

THE PHARMA MINI MBA

TOPICALS: CREAMS, LIQUIDS, OINTMENTS AND PATCHES

TURNING SCIENCE INTO SALES

US DRUG APPROVAL PROCESS

VARIATIONS TO MARKETING AUTHORISATIONS

WORKING THROUGH DRUG DEVELOPMENT:
Winter School


Management Forum, Biotech Conferences and Seminars

Pharmaceutical and Life Sciences

2005

PHARMACOVIGILANCE
Introductory course designed specifically for personnel involved in Clinical Trials, Clinical Studies and Post-Marketing
10th February
Download the brochure
Conference No A2-1405

Note this Number & Register | Request Brochure
Top of page | Home | Back

CHANGES IN THE NHS – IMPLICATIONS FOR THE PHARMACEUTICAL INDUSTRY
10 February

Download the brochure
The expert speaker panel at this meeting will explore the enormous change taking place in the NHS - What are the actual implications here for a major supplier to the NHS – the Pharmaceutical Industry –and could there be more opportunities than threats ? Should the Industry continue to be thinking of different ways of working with the NHS and seeking new kinds of partnership arrangements? This meeting will address some of these key issues
Conference No A2-4205
Note this Number & Register | Request Brochure
Top of page | Home | Back

PHARMACOVIGILANCE: COMPLIANCE & QUALITY ASSURANCE
11 February
Download the brochure
Conference No A2-1305

Note this Number & Register | Request Brochure
Top of page | Home | Back

CONTROLLING EXCIPIENTS:
14 February
Download the brochure
Pharmaceutical and Regulatory Matters. Licensing - Pharmacopoeias - Good Manufacturing Practices - Innovative Application of Testing Methods
Conference No A2-6105

Note this Number & Register | Request Brochure
Top of page | Home | Back

CTD: CLINICAL OVERVIEW AND CLINICAL SUMMARY
16 February

Download the brochure
Latest guidance on how to prepare the Clinical Overview and Summary in accordance with regulatory expectations.
Conference No A2-1205

Note this Number & Register | Request Brochure
Top of page | Home | Back

HOW TO PREPARE CLINICAL SOPs
18 February

Download the brochure
This SOP course has been specifically designed to help you develop the skills to write, review and manage SOPs and in particular to be able to comply with the new Clinical Trial Directive. SOPs play a vital and practical role in ensuring compliance with this important Directive. It is essential therefore to have a number of new SOPs written, and for several existing SOPs to be updated, otherwise this is likely to result in major findings by regulatory inspectors.
Conference No A2-4305
Note this Number & Register | Request Brochure
Top of page | Home | Back

Design and Conduct of
CLINICAL TRIALS IN RESPIRATORY MEDICINE
20/21 February

Download the brochure

This meeting will present expert detailed overviews of key aspects of the design and conduct of clinical trials with respiratory disorders including asthma, COPD, allergic rhinitis and paediatric conditions.
Conference No A2-1105
Note this Number & Register | Request Brochure
Top of page | Home | Back

ASSAYS FOR CHARACTERISING CLINICAL BIOLOGICAL MACROMOLECULES
Technical and Regulatory Challenges
23 February

Download the brochure

This seminar will address the role and significance of biological assays, and their application during the development, routine manufacture and preclinical and clinical testing of this product class. The nature and applications of bioassays and complementary physicochemical analysis of biological macromolecules will be set in the context of generating quality, safety and efficacy data for regulatory use in the drug development and approval process.
Conference No A2-8605
Note this Number & Register | Request Brochure
Top of page | Home | Back

PHARMACEUTICAL REGULATORY AFFAIRS IN THE MIDDLE EAST
24/25 February

Download the brochure
The aim of this meeting is to provide an understanding of the key areas of regulatory affairs in the Middle East, including Turkey and Israel, focusing on the practical aspects to assist regulatory activities in the region and will include opportunities for interactive discussions/break-out sessions.
Conference No A2-6005
Note this Number & Register | Request Brochure
Top of page | Home | Back

THE PHARMA MINI MBA
28 February - 2 March

Download the brochure
This intensive three day course covers the core areas of an MBA and applies these skills to the pharmaceutical industry – using industry case studies and your own issues. This ‘Mini MBA’ is especially designed to build your management skills for the future and to enable you to more effective and efficient. This three day interactive workshop will work through live issues impacting on the Industry and on participants directly. Key benefits are individual learning, attitude and behaviour shift and diagnosis of current business and organisational issues.
Conference No A2-4005
Note this Number & Register | Request Brochure
Top of page | Home | Back

PHARMACEUTICAL REGULATORY AFFAIRS IN ASIA
3/4 March

Download the brochure
Day I: China, Hong Kong, Macau, ASEAN: Brunei, Indonesia, Singapore and Thailand
Day II: Korea, Taiwan, ASEAN: Cambodia, Malaysia, Laos, Philippines and Vietnam

The aim of this meeting is to provide an understanding of the key areas of regulatory affairs in Asia, focusing on the practical aspects to assist regulatory activities in this region and will include the latest updates and opportunities for interactive discussions.
Conference No A3-6205
Note this Number & Register | Request Brochure
Top of page | Home | Back

IMPURITIES IMPURITIES
Chemical, Pharmaceutical, Pharmacopoeial, Biological, Microbiological, Licensing, GMP and other Regulatory Matters
3/4 March - IN BARCELONA
Download the brochure
Conference No A3-6305

Note this Number & Register | Request Brochure
Top of page | Home | Back

MONITORING TO GCP & THE EU CLINICAL TRIAL DIRECTIVE
7/8 March

Download the brochure
M
onitoring clinical trials to comply with GCP and the EU Clinical Trial Directive is vitally important to meet regulatory requirements and company SOPs. This interactive course will cover all the key aspects of monitoring a clinical trial, including This will include planning and preparation for setting up clinical trials, understanding the responsibilities at both the study site and the sponsor site, and how to carry out the crucial study site visits
Conference No A3-4205
Note this Number & Register | Request Brochure
Top of page | Home | Back

SUCCESSFUL MEDICAL WRITING
9-11 March

Download the brochure
This intensive and interactive course combines lectures with practical exercises to provide a thorough introduction to the basics of medical writing that goes beyond the usual ‘overview’ courses. It will provide in-depth training in general writing and data presentation skills, and specifically in the kind of documents most frequently encountered in clinical research.
Participants will learn both the theoretical and practical aspects of writing for regulatory authorities as well as the sensible use of international guidelines, standards and useful writing tips. Many illustrative examples will be used, drawn from the seminar leaders’ wide experience of the pharmaceutical industry.
Conference No A3-3205
Note this Number & Register | Request Brochure
Top of page | Home | Back

PHARMACOKINETICS/DYNAMICS: ADVANCED COURSE
10 March
Download the brochure

For some years Scientific literature has discussed building models to aid understanding of pharmacokinetic and pharmacodynamic processes that underlie drug action. However, within the drug development environment, it is only relatively recently that the prospective application of exposure response relationship characterisation has become more widespread.Climate changes with the Pharmaceutical Industry and Regulatory Agencies are driving the need for a more comprehensive adoption of these approaches.As the product of drug development is "knowledge", and its appropriate utilisation is essential in permitting the pharmaceutical industry to meet future challenges, modelling, simulation and CATD can provide an important technical solution to "knowledge management" strategies.

Conference No A3-1205
Note this Number & Register | Request Brochure
Top of page | Home | Back

BIOTECHNOLOGY FOR THE NON-BIOTECHNOLOGIST
10/11 March
    
The purpose of this seminar is to provide non-biotechnologists with the basic theory to understand the principles, techniques and potentials of biotechnology. Biotechnology is the use of biological processes to provide useful products, services and environmental management.Biotechnology combines disciplines such as molecular biology, biochemistry, chemistry microbiology, chemical engineering and computing. This rapidly advancing science offers new and exciting opportunities to mankind, especially in the fight against disease.
Conference No M3-6405

Note this Number & Register | Request Brochure
Top of page | Home | Back

CRITICAL SUCCESS FACTORS FOR POM TO P SWITCHING
14 March

Download the brochure
The reclassification of prescription medicines from POM to P can benefit the pharmaceutical industry, by giving the potential to extend the commercial life of products whose patents have expired, and to allow advertising to the public of the deregulated products, so long as the indication is suitable. However, in the P market the payback period is significantly longer and the challenge of delivering acceptable and profitable growth is much greater. This seminar will examine the opportunities and issues around successful switching. Recent switches will be examined to identify what went well and what could be improved upon.
Conference No A3-4305
Note this Number & Register | Request Brochure
Top of page | Home | Back

REGULATORY ASPECTS OF HERBAL MEDICINE
14 March

Download the brochure
The regulatory landscape for Herbal Medicinal Products is at the point of change. The European Commission has issued a new Directive to regulate the sale and supply of Traditional Herbal Medicinal Products. The Directive amends Directive 2081/83EC, which regulates the sale and supply of all medicinal substances and products. The Directive will have long term and far reaching effects upon the market for Herbal Medicinal Products throughout the European Community. This seminar is designed to address many of the issues involved, including Pharmaceutical GMP, Quality Standards, Safety and the qualifying criteria for efficacy. Estimates of approximate timetables for implementation will also be discussed.

Conference No A3-4405
Note this Number & Register | Request Brochure
Top of page | Home | Back

MICROBIOLOGY FOR THE NON-MICROBIOLOGIST: A Guide to Survival
14/15 March
IN AMSTERDAM, THE NETHERLANDS
Download the brochure
Microbiological issues play a key part in the production and control of manufactured items. The object of this seminar is to provide non-microbiologists with an overview of the basic theory and practical relevance of microbiology as it relates to the working environment.
Conference No M3-6005

Note this Number & Register | Request Brochure
Top of page | Home | Back

ADR MONITORING AND SAFETY SURVEILLANCE STRATEGIES IN EUROPE AND THE USA
15/16 March
Download the brochure
This year's conference will concentrate on the challenges and opportunities of utilising observational databases, both in Europe and the US. Methods of communication of drug safety information both electronically and operationally, prescription event monitoring, medical dictionaries, postmarketing safety studies and signal generation issues will be reviewed as well as methods of managing global pharmaceutical changes. European strategies of risk management and issues during development and the product life cycle will be discussed and also the role of the qualified person.
Conference No A3-1005
Note this Number & Register | Request Brochure
Top of page | Home | Back

NICE & THE PHARMACEUTICAL INDUSTRY
In association with the National Institute for Clinical Excellence
17 March
Download the brochure
The National Institute of Clinical Excellence (NICE) was set up in 1999 as a Special Health Authority, with the objective of improving the quality of care NHS professionals provide their patients. Because NICE is required to consider both clinical issues as well as cost effectiveness, in formulating its advice, its role and guidance is sometimes controversial. This meeting will bring together experts from NICE itself, as well as Industry representatives, to assess the importance of the Institute and clarify its current and future roles. This includes the implications of NICE taking on the functions of the Health Development Agency The appraisal process and clinical guidelines process will both be discussed, as well as the key issue of the implementation of NICE guidance.
Conference No A3-4005

Note this Number & Register | Request Brochure
Top of page | Home | Back

BORDERLINES BETWEEN COSMETICS AND DRUGS
18 March

Download the brochure
There is increasing interest in the medicinal use of cosmetics. The reasons for this include the trends to self medication and pharmacy treatments plus the increasing numbers of individuals who present with their skin related complaints. In addition, there is a growing recognition of a pharmacological activity and clinical usefulness of many agents previously classified as cosmetics. This important meeting will address the main issues surrounding the shifting borderline between cosmetics and drugs, including the latest statutory procedures and how Industry can work within the Regulations
Conference No A3-4105

Note this Number & Register | Request Brochure
Top of page | Home | Back

THE FDA GENERIC DRUG APPROVAL PROCESS
4 April
Download the brochure
This seminar will highlight new changes to the US generic drug regulations and provide an overview of the submission of documents to the FDA for approval of generic drugs. Participants will gain a better understanding of the US generic drug approval process and the underlying scientific and regulatory principles involved. Guidelines for each aspect of research will be provided, as well as information on the structuring of submissions. Information on maintaining ongoing relationships with the FDA will also be discussed. Attendance at this seminar will enable delegates to provide the FDA with the necessary information and obtain product approval.
Conference No A4-4305
Note this Number & Register | Request Brochure
Top of page | Home | Back

VARIATIONS TO MARKETING AUTHORISATIONS
4 April

Download the brochure
An introduction to the EC system for variations with practical advice on the preparation and submission of variation applications using the various European procedures. Including: Regulations of the European Commission and procedures in practice; pharmaceutical variations; Clinical Variations
Conference No A4-1205
Note this Number & Register | Request Brochure
Top of page | Home | Back

ABRIDGED PRODUCT LICENCE APPLICATIONS
5 April

Download the brochure
An intensive course examining the current requirements for those with a basic knowledge of the application procedure

Conference No A4-1305
Note this Number & Register | Request Brochure
Top of page | Home | Back

FDA APPROVAL PROCESS FOR BIOLOGICAL PRODUCTS
7/8 April

Download the brochure
This seminar will provide an overview of the FDA system for approval of biological products. Participants will receive a foundation of knowledge about the biological approval process and the underlying scientific and regulatory principles involved. Guidelines for each aspect of research will be provided as well as information on submissions and post-approval documents. Information on maintaining ongoing relationships with the FDA will also be discussed. Attendance at this seminar will enable delegates to provide the FDA with the necessary information to obtain product approval.
Conference No B4-8505
Note this Number & Register | Request Brochure
Top of page | Home | Back

GCP COURSE - FOUNDATION LEVEL
7/8 April

Download the brochure
With the implementation of the Clinical Trial Directive it is now essential to show that both the sponsor staff and investigator site staff can demonstrate a good knowledge of GCP and the Clinical Trial Directive. Inspectors from the regulatory authorities will ask for evidence that all study staff have received GCP training and it is also essential that investigator site staff can demonstrate competence in GCP both to inspectors and as evidence of suitability of investigator staff to the Ethics Committee review. This course will take you through the key areas of the GCP and the Clinical Trial Directive with an optional validated Certification examination to assess your knowledge of GCP standards.

Conference No A4-4105

Note this Number & Register | Request Brochure
Top of page | Home | Back

A discounted rate is available if both courses booked together
PHARMACOKINETICS: WORKSHOP FOR BEGINNERS
12 April
Download the brochure
This one-day course is intended to provide a basic knowledge and understanding of the main principles and concepts of Pharmacokinetics and Pharmacodynamics, as opposed to an appreciation of their place and utility in drug development. The day will provide a theoretical overview and will be a useful grounding for the following intermediate course. There willbe equations, but they will be small ones!
Conference No A4-1005
Note this Number & Register | Request Brochure
Top of page | Home | Back
PHARMACOKINETICS: INTERMEDIATE COURSE
13/14 April
Download the brochure
Pharmacokinetics and metabolism are now accepted as key disciplines in drug development, providing an insight into differences in drug action within and between species. Unfortunately for many people it is also one of the more complex to understand and to put into practice, particularly with the new approaches such as in-vivo metabolism, genetic polymorphism, interaction studies kinetic-dynamic modelling, bioavailability, population kinetics, biotechnology etc. The lecturers will provide information on the use and benefits of pharmacokinetics in drug development and how it affects drug discovery.
Conference No A4-1105

Note this Number & Register | Request Brochure
Top of page | Home | Back

STABILITY TESTING
Current Issues - Approaches - Outcomes
14/15 April
Download the brochure
This conference will survey and probe numerous issues concerning drug substance and drug product stability. The relevance of ICH and other guidelines will be demonstrated and delegates will learn how to generate re-test dates for drug substances and shelf lives for drug products.
Conference No A4-6205

Note this Number & Register | Request Brochure
Top of page | Home | Back

PATENTABILITY PROBLEMS IN MEDICAL TECHNOLOGY
15 April
Download the brochure

The patenting of medical methods (methods of treatment by surgery, therapy or diagnostic methods) has always been a controversial topic under all patent laws, and subject to varying jurisprudence, and the question arises as to the degree to which there are specific aspects of patent law relating to this significant branch of technology. This seminar will attempt to show how the provisions of the EPC are handled in practice by the EPO.
Conference No H4-3205
Note this Number & Register | Request Brochure
Top of page | Home | Back

BRAILLE FOR PHARMACEUTICAL PACKAGING
19/20 April

Conference No M4-6105
Note this Number & Register | Request Brochure
Top of page | Home | Back

GMP FOR IMPs: GOOD MANUFACTURING PRACTICE FOR INVESTIGATIONAL MEDICINAL PRODUCTS
GCP DIRECTIVE          GMP DIRECTIVE         ANNEX 13

21 April

Download the brochure
Ensure that you are in compliance: Are you aware that Clinical Research Personnel should be trained to GMP related to IMP?
Conference No A4-6605
Note this Number & Register | Request Brochure
Top of page | Home | Back

CLINICAL TRIALS: AUDIT AND INSPECTION
25 April
Download the brochure
This course will enable you to learn how to prepare to be audited and inspected in the new regulatory environment. It will be equally useful to those wanting to understand how to carry out an audit. You will learn what to expect from an audit and regulatory inspection, the different types of audit, review audit and inspection findings, how to manage post audit procedures such as responding to audit and inspection reports. You will also gain an insight from an European Community Inspectorate.
Conference No A4-4005

Note this Number & Register | Request Brochure
Top of page | Home | Back

'SMART' PHARMA PROCESSES
28/29 April

Download the brochure
Innovative approaches to ensuring that key objectives are met are being investigated at all levels in the Pharma Industry. Process re-engineering is now critically important to leading pharmaceutical organisations - with fewer NCE reaching the market place, costs of drug development rising, increasing regulatory requirements, and government pressures on pricing to name but a few. Pharma is having to focus on extending its product drug life-cycles, on other value creating opportunities, and process re-engineering will help ensure financial growth and stay ahead of the competition. This workshop will help you to deliver your department’s, team’s and individual’s goals more effectively by becoming significantly smarter about how you do things within your department processes.

Conference No A4-4205
Note this Number & Register | Request Brochure
Top of page | Home | Back

EU CHEMISTRY AND PHARMACY REGULATORY PROCEDURES AND REQUIREMENTS FOR MARKETING AUTHORISATION APPLICATIONS
12/13 May
in CORK, IRELAND
Download the brochure
The Pharmaceutical Dossier
(CTD ‘Quality’ Modules 2.3 and 3)

Conference No A5-6005

Note this Number & Register | Request Brochure
Top of page | Home | Back

TOPICALS: CREAMS, LIQUIDS, OINTMENTS AND PATCHES
Pharmaceutical and Regulatory Matters
17 May
Conference No A5-6105
Note this Number & Register | Request Brochure
Top of page | Home | Back

INTRODUCTORY OVERVIEW OF THE PHARMACEUTICAL INDUSTRY
23 May
Download the brochure
For all staff working throughout the Pharmaceutical Industry – especially non-technical staff, new to an area/department, those new to the industry and those wanting to understand what colleagues in other departments are trying to achieve and why.
Conference No P5-3305
Note this Number & Register | Request Brochure
Top of page | Home | Back

EU CLINICAL TRIAL DIRECTIVE - ONE YEAR ON
24 May
Conference No A5-4205
Note this Number & Register | Request Brochure
Top of page | Home | Back

EUROPEAN REGULATORY PROCEDURES AND STANDARDS
This course aims to fit in all the regulatory essentials – if you can only spare 3 days out of the office, then this is the course for you.
25-27 May

Download the brochure
The course is designed to offer both an introduction to EU regulatory topics and an update on current issues and recent changes.

Conference No A5-1005
Note this Number & Register | Request Brochure
Top of page | Home | Back

THE ROLE OF THE QUALIFIED PERSON IN PHARMACOVIGILANCE
26 May

The brochure for this meeting will be available shortly
This seminar will offer guidance from members of industry and the regulators as to the requirements laid down, and examples given of role models used in different sized companies. Special problems will be discussed, with practical advice as to fuulfilling the legal requirements.
Conference No A5-1105
Note this Number & Register | Request Brochure
Top of page | Home | Back

QUALITY (CMC) CONSIDERATIONS FOR JAPAN
14 June

This new seminar will include the impact of the PAL revisions to CMC documentation, latest MHLW information on the new system for Licensing and an overview of potential review issues and frequently asked questions on the quality aspects of a JNDA.
Conference No A6-6005

Note this Number & Register | Request Brochure
Top of page | Home | Back

BASIC COURSE ON PHARMACOVIGILANCE
15-17 June

This course aims to provide basic training for those concerned with pharmacovigilance. New entrants as well as experienced operators in drug safety monitoring will benefit from the mixture of scientific knowledge and practical guidance. In addition, detailed information will be provided on regulatory developments in pharmaocvigilance in Europe and the USA.
Conference No A6-1105

Note this Number & Register | Request Brochure
Top of page | Home | Back

PHARMACEUTICAL APPLICATIONS IN THE EU
7/8 July
Download the brochure
The seminar will give the attendees an understanding of the requirements and registration procedures in the EU. The workshop will help the participants to consolidate their understanding of the complexity of the process.
Conference No A7-6005
Note this Number & Register | Request Brochure
Top of page | Home | Back

CHEMICAL REFERENCE STANDARDS
July date to be confirmed

Conference No M7-6305
Note this Number & Register | Request Brochure
Top of page | Home | Back

EU CHEMISTRY AND PHARMACY REGULATORY PROCEDURES AND REQUIREMENTS FOR MARKETING AUTHORISATION APPLICATIONS
26/27 September
in BUDAPEST, HUNGARY
Download the brochure
The Pharmaceutical Dossier
(CTD ‘Quality’ Modules 2.3 and 3)

Conference No A9-6105

Note this Number & Register | Request Brochure
Top of page | Home | Back

BIOTECHNOLOGY FOR THE NON-BIOTECHNOLOGIST
29/30 September

The purpose of this seminar is to provide non-biotechnologists with the basic theory to understand the principles, techniques and potentials of biotechnology. Biotechnology is the use of biological processes to provide useful products, services and environmental management. Biotechnology combines disciplines such as molecular biology, biochemistry, chemistry microbiology, chemical engineering and computing. This rapidly advancing science offers new and exciting opportunities to mankind, especially in the fight against disease.
Conference No M9-6005

Note this Number & Register | Request Brochure
Top of page | Home | Back

STABILITY TESTING
Current Issues - Approaches - Outcomes
6/7 October
This conference will survey and probe numerous issues concerning drug substance and drug product stability. The relevance of ICH and other guidelines will be demonstrated and delegates will learn how to generate re-test dates for drug substances and shelf lives for drug products.
Conference No A10-6105
Note this Number & Register | Request Brochure
Top of page | Home | Back

EU CHEMISTRY AND PHARMACY REGULATORY PROCEDURES AND REQUIREMENTS FOR MARKETING AUTHORISATION APPLICATIONS
17/18 November
in BARCELONA, SPAIN
Download the brochure
The Pharmaceutical Dossier
(CTD ‘Quality’ Modules 2.3 and 3)

Conference No A11-6005

Note this Number & Register | Request Brochure
Top of page | Home | Back


If there are any other topics you would like us to cover please contact either
Zena Singer   (Pharmaceutical/Respiratory)
Ellen Walker  (GxP)
Andrea James (Medical Devices)
Sarah Spanswick  (Managerial Strategies,  Pricing & Reimbursement, Clinical Trials)

 

Tel: +44(0)1483 570099